GR63799X--a novel prostanoid with selectivity for EP3 receptors.
Bunce
K T
KT
Glaxo Group Research Ltd., Ware, Hertfordshire, U.K.
Clayton
N M
NM
Coleman
R A
RA
Collington
E W
EW
Finch
H
H
Humphray
J M
JM
Humphrey
P P
PP
Reeves
J J
JJ
Sheldrick
R L
RL
Stables
R
R
D000527:Alprostadil / Q000031:analogs & derivatives / Q000494:pharmacology / Q000633:toxicity; D000818:Animals; D002415:Cats; D003967:Diarrhea / Q000139:chemically induced; D015232:Dinoprostone / Q000494:pharmacology / Q000633:toxicity; D004285:Dogs; D016620:Enprostil; D000431:Ethanol / Q000633:toxicity; D005260:Female; D005744:Gastric Acid / Q000378:metabolism; D005753:Gastric Mucosa / Q000187:drug effects / Q000378:metabolism; D005756:Gastritis / Q000139:chemically induced / Q000517:prevention & control; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D016595:Misoprostol; D009130:Muscle, Smooth / Q000187:drug effects; D009215:Myometrium / Q000187:drug effects; D011459:Prostaglandins E, Synthetic / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D011982:Receptors, Prostaglandin / Q000187:drug effects* / Q000378:metabolism; D014590:Uterine Contraction / Q000187:drug effects
D011459:Prostaglandins E, Synthetic; D011982:Receptors, Prostaglandin; D016595:Misoprostol; C067522:GR 63799X; D000431:Ethanol; D006632:Histamine; D000527:Alprostadil; D016620:Enprostil; D015232:Dinoprostone; D007213:Indomethacin